Literature DB >> 11291594

The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide.

M V Clément1, J Ramalingam, L H Long, B Halliwell.   

Abstract

Reports about the effects of ascorbate (vitamin C) on cultured cells are confusing and conflicting. Some authors show inhibition of cell death by ascorbate, whereas others demonstrate that ascorbate is cytotoxic. In this report, using three different cell types and two different culture media (Dulbecco's modified Eagle's medium and RPMI 1640), we show that the toxicity of ascorbate is due to ascorbate-mediated production of H2O2, to an extent that varies with the medium used to culture the cells. For example, 1 mM ascorbate generates 161 +/- 39 microM H2O2 in Dulbecco's modified Eagle's medium and induces apoptosis in 50% of HL60 cells, whereas in RPMI 1640 only 83 +/- 17 microM H2O2 is produced and no apoptosis is detected. Apoptosis is prevented by catalase, and direct addition of H2O2 at the above concentration to the cells has similar effects to ascorbate. These results show that ascorbate itself is not toxic to the cell lines used and that effects of ascorbate in vivo cannot be predicted from studies on cultured cells. The ability of ascorbate to interact with different cell culture media to produce H2O2 at different rates could account for many or all of the conflicting results obtained using ascorbate in cultured cell assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11291594     DOI: 10.1089/152308601750100687

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  55 in total

1.  Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.

Authors:  Galina G Kramarenko; Werner W Wilke; Disha Dayal; Garry R Buettner; Freya Q Schafer
Journal:  Free Radic Biol Med       Date:  2006-01-19       Impact factor: 7.376

Review 2.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

Review 3.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

Review 4.  Targeting cancer vulnerabilities with high-dose vitamin C.

Authors:  Bryan Ngo; Justin M Van Riper; Lewis C Cantley; Jihye Yun
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

5.  Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Authors:  Qi Chen; Michael Graham Espey; Murali C Krishna; James B Mitchell; Christopher P Corpe; Garry R Buettner; Emily Shacter; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

6.  Combined supplementation of ascorbic acid and thyroid hormone T3 affects tenocyte proliferation. The effect of ascorbic acid in the production of nitric oxide.

Authors:  Viviana di Giacomo; Martina Berardocco; Marialucia Gallorini; Francesco Oliva; Alessia Colosimo; Amelia Cataldi; Nicola Maffulli; Anna C Berardi
Journal:  Muscles Ligaments Tendons J       Date:  2017-05-10

7.  Breaking down, starting up: can a vitamin C-enriched gelatin supplement before exercise increase collagen synthesis?

Authors:  Mark Levine; Pierre-Christian Violet
Journal:  Am J Clin Nutr       Date:  2016-12-21       Impact factor: 7.045

8.  Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.

Authors:  Juan M Cárcamo; Alicia Pedraza; Oriana Bórquez-Ojeda; Bing Zhang; Roberto Sanchez; David W Golde
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

9.  Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.

Authors:  Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

10.  Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.

Authors:  Diarmuid M Moran; Hong Shen; Carl G Maki
Journal:  BMC Cell Biol       Date:  2009-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.